17. When Pitney Bowes moved medications for chronic conditions to the lowest (least expensive) tier of the pharmacy benefit plan __________.
18. There is a strong connection between copayments, adherence to therapy, and improved patient outcomes.
Do not agree Strongly agree
1 2 3 4 5 6
19. Newer agents need to be considered earlier in the management of diabetic patients with poor glycemic control.
Do not agree Strongly agree
1 2 3 4 5 6
20. Results from the Pitney Bowes benefits design model have shown that novel benefit designs are necessary to improve health outcomes in patients with chronic diseases.
Do not agree Strongly agree
1 2 3 4 5 6


| << Previous Page (1) | Page: 12 |